Speciality pharma group Alliance Pharma PLC (LON:APH) has appointed two new non-executive directors to its board.
Alliance said the appointments of Jo Le Couilliard and Richard Jones will add further international business experience and capital markets expertise.
Le Couilliard spent most of her career at FTSE 100 drugmaker GlaxoSmithKline PLC (LON:GSK), while former investment banker Jones is the current chief financial officer of Mereo Biopharma Group PLC (LON:MPH).
Both directors qualified as accountants at Big Four accounting firm PricewaterhouseCoopers (PwC).
“I am delighted to welcome Jo and Richard to Alliance's board,” said chairman David Cook.
“They bring a huge breadth of relevant and varied experience to Alliance. Jo's extensive experience at GSK included a senior sales and marketing position in Asia Pacific, which represents Alliance's fastest growing region.
“Richard, from his work as an investment banker and as a financial executive, brings a depth of relevant capital markets experience. I look forward to their contribution to the company's ongoing development into a leading international healthcare business.”
Alliance shares were flat at 67.2p in early deals on Monday.